Résultats: 19

    Ongoing living update of potential COVID-19 therapeutics: summary of rapid systematic reviews - 13 September 2021

    The vast amount of data generated by clinical studies of potential therapeutic options for COVID-19 presents important challenges. The new data must be interpreted quickly so that prescribers can make optimal treatment decisions with as little harm to patients as possible, and so that medicines manufactu...

    Ongoing living update of potential COVID-19 therapeutics options: summary of evidence - 20 April 2021

    The vast amount of data generated by clinical studies of potential therapeutic options for COVID-19 presents important challenges. The new data must be interpreted quickly so that prescribers can make optimal treatment decisions with as little harm to patients as possible, and so that medicines manufactu...

    Ongoing living update of potential COVID-19 therapeutics options: summary of evidence - 5 August 2021

    The vast amount of data generated by clinical studies of potential therapeutic options for COVID-19 presents important challenges. The new data must be interpreted quickly so that prescribers can make optimal treatment decisions with as little harm to patients as possible, and so that medicines manufactu...

    Ongoing living update of potential COVID-19 therapeutics options: summary of evidence - 22 June 2021

    The vast amount of data generated by clinical studies of potential therapeutic options for COVID-19 presents important challenges. The new data must be interpreted quickly so that prescribers can make optimal treatment decisions with as little harm to patients as possible, and so that medicines manufactu...

    Ongoing living update of potential COVID-19 therapeutics options: summary of evidence - 14 July 2021

    The vast amount of data generated by clinical studies of potential therapeutic options for COVID-19 presents important challenges. The new data must be interpreted quickly so that prescribers can make optimal treatment decisions with as little harm to patients as possible, and so that medicines manufactu...

    Ongoing living update of potential COVID-19 therapeutics options: summary of evidence - 6 May 2021

    The vast amount of data generated by clinical studies of potential therapeutic options for COVID-19 presents important challenges. The new data must be interpreted quickly so that prescribers can make optimal treatment decisions with as little harm to patients as possible, and so that medicines manufactu...

    Ongoing living update of potential COVID-19 therapeutics options: summary of evidence - 27 May 2021

    The vast amount of data generated by clinical studies of potential therapeutic options for COVID-19 presents important challenges. The new data must be interpreted quickly so that prescribers can make optimal treatment decisions with as little harm to patients as possible, and so that medicines manufactu...

    Ongoing living update of potential COVID-19 therapeutics options: summary of evidence - 26 August 2021

    The vast amount of data generated by clinical studies of potential therapeutic options for COVID-19 presents important challenges. The new data must be interpreted quickly so that prescribers can make optimal treatment decisions with as little harm to patients as possible, and so that medicines manufactu...

    Ongoing living update of potential COVID-19 therapeutics: summary of rapid systematic reviews - 25 March 2021

    The urgent need for evidence on measures to respond to the COVID-19 pandemic had led to a rapid escalation in numbers of studies testing potential therapeutic options. The vast amount of data generated by these studies must be interpreted quickly so that physicians have the information to make optimal tr...

    Ongoing living update of potential COVID-19 therapeutics: summary of rapid systematic reviews - 29 January 2021

    The vast amount of data generated by clinical studies of potential therapeutic options for COVID-19 presents important challenges. This new information must be interpreted quickly so that prescribers can make optimal treatment decisions with as little harm to patients as possible, and so that medicines m...